Dual targeting of CCR2+ monocytes and neutrophils enhances anti-tumor immunity
Klaire Yixin Fjæstad, Astrid Zedlitz Johansen, Hannes Linder…·Daniel Hargbøll Madsen
This study shows that targeting both CCR2+ monocytes and neutrophils improves anti-tumor immunity by reducing tumor growth and enhancing CD8+ T cell infiltration.